NV5 Global (NVEE) Tops Q2 EPS by 15c

NV5 Global (NASDAQ: NVEE) reported Q2 EPS of $1.49, $0.15 better than the analyst estimate of $1.34. Revenue for the quarter came in at $202.7 million versus the consensus estimate of $197.93 million.

For earnings history and earnings-related data on NV5 Global (NVEE) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Yeti Holdings Inc. (YETI) PT Raised to $45 at Stifel on Beat and Raise Q2 Results
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94